Pessac

France

514 total trials 231 recruiting

Filter these 514 trials by phase, condition, sponsor and more.

Open in Search →

A Study to Evaluate the Efficacy and Safety of Polatuzumab Vedotin in Combination with Rituximab and CHP (R-CHP) Versus Rituximab and CHOP ( … Ended

2024-516904-40-00 5 2018-03-27 Previously Untreated Diffuse large B-cell lymphoma (DLBCL)
A clinical study to compare the safety, effectiveness and pharmacokinetics (the way the body absorbs, distributes, and gets rid of a drug) o … Ended

2023-507143-11-00 5 2017-11-08 Precancerous form of blood cancer in the bone marrow
A Study of Venetoclax Co-Administered with Low Dose Cytarabine Versus Low Dose Cytarabine in Untreated Patients with Acute Myeloid Leukemia … Ended

2024-513630-37-00 5 2017-10-24 Acute Myeloid Leukemia
A Study of Venetoclax in Combination with Azacitidine Versus Azacitidine in previously untreated Subjects with Acute Myeloid Leukemia who ar … Ended

2024-513631-25-00 5 2017-08-17 Acute Myeloid Leukemia
Interest of Intra-nodal injection of gentamicin for the treatment of suppurated cat scratch disease's lymphadenitis Ended

2024-512037-32-00 5 2017-05-31 Bartonellosis
A study of Ibrutinib in combination with Rituximab versus Placebo in combination with Rituximab in treatment of patients with Follicular Lym … Ended

2023-507271-21-00 5 2017-04-11 Follicular Lymphoma
Tepotinib Phase II study in advanced lung cancer harboring MET exon 14 (METex14) skipping alterations and MET amplification Ended

2024-512003-39-00 4 2016-07-18 Lung Cancer
A Phase III, Randomized, Open-label, Clinical Trial to Compare Pembrolizumab with Brentuximab Vedotin in Subjects with Relapsed or Refractor … Ended

2022-500400-22-00 5 2016-06-23 Hodgkin lymphoma
Mavacamten Impact on Myocardial Structure in Obstructive Hypertrophic Cardiomyopathy Ended

2022-502316-36-00 11 Symptomatic Obstructive Hypertrophic Cardiomyopathy
Phase 3 Study of Tamibarotene Plus Azacitidine in Patients Selected for RARA-positive Higher-risk MDS (SELECT-MDS-1) Ended

2023-510361-97-00 5 Newly Diagnosed RARA-positive Adult Patients with Higher-risk Myelodys

Showing 505–514 of 514 trials